StonvexLoading…
StonvexCore line items from PCG's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
Quarterly filings sourced directly from SEC EDGAR. Real-time earnings actuals are in the Earnings panel above.
| Metric | Q3 2026 (Est.) Expected 2026-07-29 | Q3 2021 2021-09-30 | Q2 2021 2021-06-30 | Q1 2021 2021-03-31 | Q3 2020 2020-09-30 |
|---|---|---|---|---|---|
Revenue | $6.50B | $15.40B | $9.93B | $4.72B | $13.72B |
Operating Income | Not available | $1.24B | $938.00M | $304.00M | $1.33B |
Net Income | Not available | $-564.00M | $401.00M | $123.00M | $-1.51B |
EPS (Diluted) | $0.38 | $-0.29 | $0.24 | $0.06 | $-1.50 |
Total Assets | Not available | $103.56B | $100.49B | $98.56B | $95.59B |
Total Liabilities | Not available | Not available | Not available | Not available | Not available |
Cash & Equivalents | Not available | $420.00M | $307.00M | $229.00M | $464.00M |
Free Cash Flow OCF − CapEx | Not available | $-3.42B | $-2.39B | $-580.00M | $-24.69B |
Shares Outstanding | Not available | 1.99B | 1.99B | 1.99B | 1.98B |